The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 373.50
Bid: 371.50
Ask: 372.50
Change: 6.00 (1.63%)
Spread: 1.00 (0.269%)
Open: 367.00
High: 374.50
Low: 366.00
Prev. Close: 367.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update November 2021

24 Nov 2021 07:00

RNS Number : 3205T
Breedon Group PLC
24 November 2021
 

 

 

24 November 2021

 

BREEDON GROUP PLC

 

Full year result to be slightly above top end of current market expectations*

Strong trading performance and robust cost management

 

 

Breedon Group plc ("Breedon" or the "Group"), a leading vertically integrated construction materials group in Great Britain and Ireland today reports on its performance for the 10 months to 31 October 2021.

 

Trading performance

· Group revenue of £1,045m up 31% versus the same period in 2019

· Like-for-like1 revenue increased 15% on the same period in 2019

· Positive margin performance reflects dynamic pricing and cost recovery actions

· Layered hedging policy continued to mitigate key commodity cost pressures

 

Breedon has continued to benefit from strong end markets, with demand levels remaining encouraging across the Group. Trends evident in the first half have persisted with momentum in residential housebuilding and infrastructure spending continuing to drive volume growth. Ireland continued to gain traction during the second half following the lifting of Government restrictions on non-essential construction.

 

Pricing actions have increasingly reflected the dynamic cost environment and our layered hedging policy has delivered visibility of energy and carbon costs. As indicated in July, allowing for the natural lag to implement price adjustments, we have secured full cost recovery in the second half, leading to margin improvement.

 

Underlying EBIT2 performance for the 2021 full year will now be stronger than we expected and, assuming no adverse weather events, will be slightly above the upper end of the range of market expectations*.

 

Financial position

Cash generation has remained strong and the Group has continued to degear, assisted by lower levels of capital expenditure. Our two-year capital investment plan, with its emphasis on sustainability linked projects, is unchanged and amounts to c.£170m over 2021 and 2022. However, we now expect capex for 2021 will be c.£70m with the balance deferred into next year, principally as a result of extended procurement lead times.

 

Outlook

The recovery we experienced in the first half of 2021 has been sustained, with supply chain disruption managed effectively by our local teams who have stayed close to their customers and suppliers. While the dynamic cost environment is likely to persist into 2022, the medium-term outlook for our end markets and demand levels remains encouraging, with both the UK and Irish Governments committed to material long-term spending plans for construction.

 

Capital Markets Event

Breedon will host a Capital Markets Event for analysts and institutional investors at the London Stock Exchange today from 3:30 to 5:30pm with registration open from 3:00pm. The event will be webcast live and include presentations addressing the Group's strategy for long-term sustainable growth.

 

To register for the Capital Markets Event please contact pia.anand@teneo.com or visit the Breedon Investor Relations website and follow this link.  

Market expectations*

Market expectations are defined as Breedon compiled analyst consensus. As at 23 November 2021 market expectations for Underlying EBIT2 for the full year 2021 were an average of £129m with a range of £122m to £131m.

 

Notes:

1. Like-for-like reflects reported values adjusted for the impact of acquisitions and disposals.

2. Underlying EBIT is stated before acquisition-related expenses, redundancy costs, property gains and losses, amortisation of acquisition intangibles and related tax items.

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

 

 

Enquiries

 

Breedon Group plc

+44 (0) 1332 694010

Rob Wood, Chief Executive Officer

James Brotherton, Chief Financial Officer

 

Louise Turner-Smith, Head of Investor Relations

 

+44 (0) 7860 911909

Numis (NOMAD and joint broker)

+44 (0) 20 7260 1000

Ben Stoop

Oliver Hardy (NOMAD)

 

 

 

HSBC (Joint broker)

+44 (0) 20 7991 8888

Sam McLennan

Joe Weaving

 

 

 

Teneo (Public relations adviser)

+44 (0) 20 7420 3180

Nick de Bunsen

Claire Scicluna

 

 

 

About Breedon Group plc

Breedon Group plc, a leading vertically-integrated construction materials group in Great Britain and Ireland, delivers essential products to the construction sector. Breedon holds c.1bn tonnes of mineral reserves and resources with long reserve life, supplying value-added products and services, including specialty materials, surfacing and highway maintenance operations, to a broad range of customers through its extensive local network of quarries, ready-mixed concrete and asphalt plants.

The Group's two well-invested cement plants are actively engaged in a number of carbon reduction practices, which include utilising alternative raw materials and lower carbon fuels. Breedon's c.3,500 colleagues embody our commitment to 'Make a Material Difference' as the Group continues to execute its strategy to create sustainable value for all stakeholders, delivering growth through organic improvement and acquisition in the heavyside construction materials market.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEXLFLFFLZFBL
Date   Source Headline
7th Jun 20194:44 pmRNSHolding(s) in Company
7th Jun 20199:00 amRNSHolding(s) in Company
4th Jun 20191:01 pmRNSDirector / PDMR Dealings & Total Voting Rights
29th May 201912:38 pmRNSFurther re: Intended Sale of Shares
29th May 20197:05 amRNSIntended Sale of Shares
29th May 20197:00 amRNSDirectorate Change
7th May 20195:05 pmRNSDirector / PDMR Dealings & Total Voting Rights
30th Apr 20192:39 pmRNSResult of AGM
30th Apr 20197:00 amRNSAGM Statement
16th Apr 201910:14 amRNSDirectors' and PDMRs' Dealings
8th Apr 20193:12 pmRNSDirector and PDMR Dealings & Issue of Equity
2nd Apr 201912:02 pmRNSDirector and PDMR Dealings and Issue of Equity
1st Apr 20195:00 pmRNSGrant of SAYE Options and PDMR Dealings
18th Mar 20199:23 amRNSDirector Dealings
6th Mar 20197:00 amRNSAnnual Results 2018
15th Feb 201910:53 amRNSHolding(s) in Company
23rd Jan 20192:30 pmRNSBlock listing Interim Review
18th Dec 201811:20 amRNSDirectorate Change
17th Dec 201810:20 amRNSDirector/PDMR Shareholding
14th Dec 20183:46 pmRNSDirector/PDMR Shareholding
12th Dec 20182:27 pmRNSDirector/PDMR Shareholding
7th Dec 20181:00 pmRNSDirector/PDMR Shareholding
6th Dec 20184:57 pmRNSDirector/PDMR Shareholding
27th Nov 201812:00 pmRNSTotal Voting Rights
21st Nov 20187:00 amRNSTrading Update
23rd Oct 20183:55 pmRNSDirector/PDMR Shareholding
17th Oct 20184:42 pmRNSDirector/PDMR Shareholding
16th Oct 20185:00 pmRNSGrant of SAYE Options and PDMR Dealings
12th Oct 201810:00 amRNSDirector/PDMR Shareholding
1st Oct 20188:05 amRNSAppointment of Non-Executive Director
25th Sep 20184:17 pmRNSDirector/PDMR Shareholding
14th Sep 20183:21 pmRNSHolding(s) in Company
14th Sep 20183:20 pmRNSHolding(s) in Company
5th Sep 20187:01 amRNSAppointment of Non-Executive Director
5th Sep 20187:00 amRNSHalf-year Report
1st Aug 20183:57 pmRNSHolding(s) in Company
25th Jul 20182:58 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSBlock Listing Update
2nd Jul 20187:00 amRNSBREEDON COMPLETES ASSET SWAP WITH TARMAC
1st Jun 20185:30 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSAcquisition of Blinkbonny Quarry
17th May 20184:55 pmRNSGrant of SAYE Options and PDMR Dealings
11th May 20183:30 pmRNSResults of Open Offer
8th May 201812:49 pmRNSDirector and PDMR Dealings
30th Apr 20184:19 pmRNSDirector/PDMR Shareholding
27th Apr 20182:18 pmRNSAdditional Block Listing of Ordinary Shares
26th Apr 20181:29 pmRNSDirector and PDMR Dealings and Issue of Equity
26th Apr 20188:00 amRNSCMA's Review of Proposed Acquisition
24th Apr 20183:54 pmRNSResult of AGM
24th Apr 201812:15 pmRNSAppointment of Deputy Chairman

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.